Raymond James Financial Inc. Buys New Shares in AdaptHealth Corp. (NASDAQ:AHCO)

Raymond James Financial Inc. bought a new position in shares of AdaptHealth Corp. (NASDAQ:AHCO) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 20,701 shares of the company’s stock, valued at approximately $197,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Barclays PLC increased its stake in shares of AdaptHealth by 361.3% during the 3rd quarter. Barclays PLC now owns 181,240 shares of the company’s stock valued at $2,034,000 after acquiring an additional 141,949 shares during the last quarter. Principal Financial Group Inc. grew its holdings in AdaptHealth by 39.7% in the third quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock valued at $6,106,000 after purchasing an additional 154,434 shares during the period. JPMorgan Chase & Co. grew its holdings in AdaptHealth by 73.2% in the third quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company’s stock valued at $2,154,000 after purchasing an additional 81,097 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in AdaptHealth by 7.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 162,470 shares of the company’s stock worth $1,825,000 after purchasing an additional 11,757 shares during the last quarter. Finally, Reinhart Partners LLC. raised its stake in AdaptHealth by 1.1% during the fourth quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company’s stock worth $59,660,000 after purchasing an additional 68,212 shares during the period. 82.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on AHCO. Canaccord Genuity Group boosted their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Royal Bank of Canada boosted their price target on AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. UBS Group cut their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Robert W. Baird boosted their target price on AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. Finally, Truist Financial increased their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, AdaptHealth currently has a consensus rating of “Buy” and a consensus price target of $13.80.

AdaptHealth Trading Down 3.3 %

NASDAQ:AHCO opened at $8.66 on Friday. AdaptHealth Corp. has a 12 month low of $8.35 and a 12 month high of $11.90. The business’s 50-day moving average is $9.86 and its two-hundred day moving average is $10.07. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm has a market capitalization of $1.17 billion, a PE ratio of -5.25, a price-to-earnings-growth ratio of 1.08 and a beta of 1.44.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.